Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035-Reference-Cited by-同舟云学术

Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035

Published:2024-06-05 Issue:9 Volume:116 Page:1508-1512
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Garg Ashvita¹²^ORCID,Damgacioglu Haluk¹²^ORCID,Sigel Keith³^ORCID,Nyitray Alan G⁴^ORCID,Clifford Gary M⁵,Curran Thomas⁶^ORCID,Lazenby Gweneth⁷,Meissner Eric G⁸^ORCID,Sterba Katherine¹²,Sonawane Kalyani¹²^ORCID,Deshmukh Ashish A¹²

Affiliation:

1. Department of Public Health Sciences, College of Medicine, Medical University of South Carolina , Charleston, SC, USA

2. Cancer Prevention & Control Research Program, MUSC Hollings Cancer Center , Charleston, SC, USA

3. Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai , New York, NY, USA

4. Clinical Cancer Center, Medical College of Wisconsin , Milwaukee, WI, USA

5. Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO) , Lyon, France

6. Division of Colon and Rectal Surgery, Department of Surgery, Medical University of South Carolina , SC, USA

7. Department of Obstetrics and Gynecology, Medical University of South Carolina , Charleston, SC, USA

8. Division of Infectious Diseases, Medical University of South Carolina , Charleston, SC, USA

Abstract

Abstract Squamous cell carcinoma of the anus (SCCA) incidence has been rising in the United States, particularly among older adults (≥65 years). We estimated the impact of this rise on future burden (through 2035) using age-period-cohort modeling. The SCCA burden (cases/year) is expected to rise, reaching approximately 2700 among men and approximately 7000 among women in 2031-2035 (burden during 2016-2020 among men and women was approximately 2150 and approximately 4600), with most cases 65 years of age or older (61% in men and 70% in women in 2031-2035; from 40% and 46% in 2016-2020). SCCA incidence (per 100 000) is projected to rise among older men aged 65-74, 75-84, and 85 years or older (5.0, 4.9, and 4.3 in 2031-2035 vs 3.7, 3.8, and 3.4 in 2016-2020, respectively) and women (11.2, 12.6, and 8.0 in 2031-2035 vs 8.2, 6.8, and 5.2 in 2016-2020, respectively). The projected rise in SCCA burden among older adults is troubling and highlights the importance of improving early detection and clinical care.

Funder

National Cancer Institute

National Institutes of Health

National Institute on Minority Health and Health Disparities

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djae127/58384650/djae127.pdf

Reference23 articles.

1. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines;Saraiya;J Natl Cancer Inst,2015

2. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015;Deshmukh;J Natl Cancer Inst,2020

3. State variation in squamous cell carcinoma of the anus incidence and mortality, and association with HIV/AIDS and smoking in the United States;Damgacioglu;J Clin Oncol,2023

4. Incidence trends and burden of human papillomavirus-associated cancers among women in the United States, 2001-2017;Deshmukh;J Natl Cancer Inst,2021